APA:
Choi, Jiwon (2022). Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
Radiology and oncology (Ljubljana), letnik 56, številka 2, str. 185-197, VIII.
URN:NBN:SI:DOC-GA3EXV3O from http://www.dlib.si
MLA:
Choi, Jiwon. "Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer."
Radiology and oncology (Ljubljana) letnik 56. številka 2 (2022) str. 185-197, VIII.
<http://www.dlib.si/?URN=URN:NBN:SI:DOC-GA3EXV3O>